Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Tvardi Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Acumen Pharmaceuticals Inc. June 4, 202588.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 3, 2026 | Acumen Pharmaceuticals Inc. | Grant or award | +35,500 | — | — |
| Jun 4, 2025 | Acumen Pharmaceuticals Inc. | Grant or award | +12,800 | — | — |
| Jun 4, 2024 | Tvardi Therapeutics Inc. | Grant or award | +150,647 | — | — |
| Aug 17, 2023 | Acumen Pharmaceuticals Inc. | Option exercise | +39,149 | $0.72 | $28,187 |
| Aug 17, 2023 | Acumen Pharmaceuticals Inc. | Open-market sale | −39,149 | $6.48 | $253,686 |
| Aug 17, 2023 | Acumen Pharmaceuticals Inc. | Option exercise | +2,800 | $1.19 | $3,332 |
| Aug 17, 2023 | Acumen Pharmaceuticals Inc. | Open-market sale | −2,800 | $6.66 | $18,648 |
| Jun 1, 2023 | Tvardi Therapeutics Inc. | Grant or award | +32,362 | — | — |
Questions about Jeffrey L. Ives
What boards is Jeffrey L. Ives on?
Jeffrey L. Ives sits on the boards of Acumen Pharmaceuticals Inc. and Tvardi Therapeutics Inc.
How long has Jeffrey L. Ives served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.